Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Bayer Healthcare Llc patents


Recent patent applications related to Bayer Healthcare Llc. Bayer Healthcare Llc is listed as an Agent/Assignee. Note: Bayer Healthcare Llc may have other listings under different names/spellings. We're not affiliated with Bayer Healthcare Llc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Bayer Healthcare Llc-related inventors


Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)

Isolated monoclonal antibodies that bind to specific epitopes of human tissue factor pathway inhibitor (tfpi) and the isolated nucleic acid molecules encoding them are provided. Pharmaceutical compositions comprising the anti-tfpi monoclonal antibodies and methods of treating deficiencies or defects in coagulation by administration of the antibodies are also provided.. ... Bayer Healthcare Llc

Fluid injection systems and features

A system for delivering fluid to a patient including housing having at least one syringe port and a fluid control device adapted to interface with and actuate at least one syringe engaged therein. The fluid control device includes a processor configured to control a fluid delivery and to wirelessly communicate with one or more portable computers. ... Bayer Healthcare Llc

Syringe with rolling diaphragm

A rolling diaphragm syringe includes a proximal end having an end wall, a distal end having an open-ended discharge neck, a sidewall extending along a longitudinal axis, and a piston engagement portion protruding proximally from a central portion of the end wall and configured for engagement with a piston of a fluid injector. The piston engagement portion has a stem with a first end attached to the end wall, a second end extending proximally from the first end, and at least one protrusion that protrudes radially outward. ... Bayer Healthcare Llc

Variant factor viii polypeptides and methods of their production and use

This disclosure relates to variant factor viii polypeptides comprising an amino acid substitution at one or more positions within one or both of the thrombin cleavage site and the activation loop. In certain embodiments, the variant factor viii polypeptide comprises one or more amino acid substitutions within both the thrombin cleavage site and the activation loop. ... Bayer Healthcare Llc

Fluid mixing control device for a multi-fluid delivery system

The control device is used to control delivery of fluids from a multi-fluid delivery system during a medical injection procedure. The fluid delivery system includes an injector used to deliver injection fluids to a patient. ... Bayer Healthcare Llc

Plunger covers and plungers for use in syringes

A plunger cover for use with a syringe includes a sealing portion adapted to form a seal with the syringe and a central portion adapted to contact fluid within the syringe. The central portion can, for example, be more rigid than the sealing portion. ... Bayer Healthcare Llc

Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent

Pharmaceutically acceptable single parasiticidal agent compositions of imidacloprid for oral delivery to mammals to systemically control targeted blood-sucking or blood-consuming parasites, such as fleas, ticks and certain species of helminthes and scabies.. . ... Bayer Healthcare Llc

High pressure sensor for use with a fluid delivery system

A pressure sensor for use with a fluid delivery system having good sensitivity at low pressure, but also configured to remain in operating condition after being exposed to high pressures is disclosed herein. In one variation, the pressure sensor includes a fluid path set, a deformable element associated with the fluid path set and configured to deform in response to an external pressure, and a pressure transducer for monitoring deformation of the deformable element. ... Bayer Healthcare Llc

Contrast imaging agent with dissolved gas-evolving fluid

A diagnostic contrast composition includes a carrier fluid and a non-decaying gas-evolving fluid incorporated in the carrier fluid. The gas-evolving fluid has a vapor pressure sufficient to evolve the gas from a circulatory system within a lung of a patient. ... Bayer Healthcare Llc

Antibody and protein formulations

Provided are salt-free antibody and other protein formulations that are substantially isosmotic and of low viscosity. Also provided are methods for the treatment of diseases using the disclosed formulations.. ... Bayer Healthcare Llc

Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations

The present invention relates to combinations of: component a: one or more 2,3-dihydroimidazo[1,2-c]quinazoline compounds of general formula (a1) or (a2), or a physiologically acceptable salt, solvate, hydrate or stereoisomer thereof; component b: one or more substituted 5-(1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]-triazin-4-amine compounds of general formula (b), or a physiologically acceptable salt, solvate, hydrate or stereoisomer thereof; in which optionally some or all of the components are in the form of a pharmaceutical formulation which is ready for use to be administered simultaneously, concurrently, separately or sequentially, dependently of one another by the oral, intravenous, topical, local installations, intraperitoneal or nasal route; use of such combinations for the preparation of a medicament for the treatment or prophylaxis of a cancer; a kit comprising such a combination; use of biomarkers which is the loss of tumor suppressor pten or fbxw7, for predicting the sensitivity and/or resistance of a cancer patient to said compound and providing a rationale-based dosage to increase sensitivity and/or to overcome resistance; a method of determining the loss of tumor suppressor pten or fbxw7; and a method for determining perturbations in pik3ca, pik3cb, pik3cd, pik3cg, pi k3r1, pik3r2, pik3r3, pik3r4, pik3r5, fgfr1, fgfr2, fgfr3 and/or fgfr4.. . ... Bayer Healthcare Llc

Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines

The present invention relates to: use of a 2,3-dihydroimidazo[1,2-c]quinazoline compound, or of a pharmaceutical composition containing same, as a sole active agent, or of a combination of a) said compound or a pharmaceutical composition containing said compound and b) one or more further active agents, for the preparation of a medicament for the treatment or prophylaxis of endometrial cancer (hereinafter abbreviated to “ec”), particularly 1st line, 2nd line, relapsed, refractory, type i or type ii ec, or endometriosis; combinations of a) said compound and b) one or more further active agents; a pharmaceutical composition comprising said compound as a sole active agent for the treatment of endometrial cancer (hereinafter abbreviated to “ec”), particularly 1st line, 2nd line, relapsed, refractory, type i or type ii ec, or endometriosis; a pharmaceutical composition comprising a combination of a) said compound and b) one or more further active agents; use of biomarkers which is the loss of tumor suppressor pten or fbxw7, for predicting the sensitivity and/or resistance of a cancer patient to said compound and providing a rationale-based dosage to increase sensitivity and/or to overcome resistance; a method of determining the loss of tumor suppressor pten or fbxw7; and a method for determining perturbations in pik3ca, pik3cb, pik3cd, pik3cg, p1k3r1, pik3r2, pik3r3, pik3r4, pik3r5, fgfr1, fgfr2, fgfr3 and/or fgfr4.. . ... Bayer Healthcare Llc

Pharmaceutical composition for the treatment of cancer

The present invention pertains to a pharmaceutical composition comprising the compound of the formula (i) in a high concentration and at least one pharmaceutically acceptable excipient, the use of the composition for the treatment of hyper-proliforative diseases, such as cancer, either as a sole agent, or in combination with other anti-cancer therapies, and the process for preparing of said composition.. . ... Bayer Healthcare Llc

Antibody and protein formulations

Provided are salt-free antibody and other protein formulations that are substantially isosmotic and of low viscosity. Also provided are methods for the treatment of diseases using the disclosed formulations.. ... Bayer Healthcare Llc

01/18/18 / #20180015274

Multiple fluid delivery system with multi-use disposable set and features thereof

A multi-use disposable set (muds) has at least one syringe having a proximal end and a distal end spaced apart from the proximal end along a longitudinal axis. The muds further has a plunger reciprocally movable within a syringe interior between the proximal end and the distal end. ... Bayer Healthcare Llc

01/11/18 / #20180010090

Formulations and methods for increased recombinant protein production

Formulations and methods to increase the production of recombinant proteins, and other aspects, are disclosed. The formulations and methods relate to increasing mannose or calcium concentration, or both, in a cell culture medium formulation for culturing cells that express recombinant proteins. ... Bayer Healthcare Llc

01/11/18 / #20180008787

System and method for identifying a fill volume of a fluid chamber

A system and method for determining the fill volume of a fluid chamber includes a fluid injector, at least one fluid chamber in fluid communication with the fluid injector, one or more sensors positioned relative to the at least one fluid chamber and configured to detect a position of a liquid-gas interface of the fluid contained in the at least one fluid chamber, and at least one processor in communication with the sensors and the fluid injector, and configured to: determine the position of the liquid-gas interface of the fluid, calculate the volume of fluid in the at least one fluid chamber based on the position of the liquid-gas interface, and at least one of: i) display the volume of the fluid; ii) enable the fluid injector to perform an action; and iii) disable the fluid injector from performing the action.. . ... Bayer Healthcare Llc

01/11/18 / #20180008780

Quick release plunger

A syringe system and components thereof are disclosed. The system may include a syringe body having a hollow lumen, a proximal open end, and a distal end. ... Bayer Healthcare Llc

11/30/17 / #20170342162

Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)

Isolated monoclonal antibodies that bind human tissue factor pathway inhibitor (tfpi) and the isolated nucleic acid molecules encoding them are provided. Pharmaceutical compositions comprising the anti-tfpi monoclonal antibodies and methods of treating deficiencies or defects in coagulation by administration of the antibodies are also provided. ... Bayer Healthcare Llc

11/23/17 / #20170334857

Method of purifying and using 4-chloro-n-methy1-2-pyridinecarboxamide

The present invention relates to a process for preparing 4-(4-[({[4-chloro-3-(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3-fluorophenoxy)-n-methylpyridine-2-carboxamide, its salts and monohydrate.. . ... Bayer Healthcare Llc

11/23/17 / #20170333624

Self-orienting pressure jacket and pressure jacket-to-injector interface

A pressure jacket includes a barrel having a proximal end, a distal end, and a sidewall extending substantially circumferentially between the proximal end and the distal end along a longitudinal axis. The pressure jacket also includes at least one retaining member having at least one first lug protruding radially outward relative to an outer surface of the sidewall. ... Bayer Healthcare Llc

11/23/17 / #20170333619

Self-orienting pressure jacket and pressure jacket-to-injector interface

A pressure jacket for use with a fluid injector includes a barrel having a distal end, a proximal end, and a sidewall extending between the distal end and the proximal end along a longitudinal axis. The pressure jacket includes at least one engagement member protruding from a terminal portion of the proximal end of the barrel in a proximal direction along the longitudinal axis. ... Bayer Healthcare Llc

11/16/17 / #20170326106

Treatment of age related macular degeneration with a small active choroidal neovascularization lesion

Methods for treatment of wamd with an active cnv lesion of less than 50% of the total lesion size and pharmaceutical compositions for the use therein are disclosed.. . ... Bayer Healthcare Llc

10/26/17 / #20170304529

Self-orienting syringe and syringe interface

A medical injector including at least one syringe port for engaging at least one syringe and having a locking mechanism. The locking mechanism enables the syringe to self-align with the syringe port for locking engagement upon insertion of the syringe into the syringe port and to axially eject the syringe from the port upon rotational disengagement of the syringe from the port.. ... Bayer Healthcare Llc

10/12/17 / #20170290993

System and method for syringe fluid fill verification and image recognition of power injector system features

A fluid injection system and a fluid verification system for confirming that a syringe, containing a fluid for injection, is fully filled with fluid and neither has free space (i.e., air) near the distal end thereof when the syringe is provided in an upright position nor contains air bubbles. Imaging processing techniques and systems are also provided to determine various injection parameters and to verify the type and certain properties of fluid that is present within a syringe.. ... Bayer Healthcare Llc

09/21/17 / #20170267745

Factor viii glycoforms

The invention concerns glycosylated proteins having human factor viii activity. In a preferred embodiment, the protein is glycosylated with oligosaccharides that include an alpha-(2,6)-linked sialic acid and a bisecting glcnac linked to a core beta-mannose.. ... Bayer Healthcare Llc

09/14/17 / #20170258982

System and methods for pre-injection pressure prediction in injection procedures

A method of predicting peak pressure within a fluid path, which includes a tubing set and a catheter into which at least one fluid is introduced under pressure by a pressurizing system of a fluid injection apparatus, includes (a) inputting an initial injection protocol into the fluid injection apparatus according to which the at least one fluid is intended to be introduced into the fluid path; (b) predicting an expected peak pressure level that would result in the fluid path if the initial injection protocol were to be used as intended to introduce the at least one fluid into the fluid path. The expected peak pressure level is determined before commencement of the initial injection protocol according to at least one model on the basis of a flow rate of the at least one fluid, at least one catheter characteristic, and a viscosity of the at least one fluid. ... Bayer Healthcare Llc

08/24/17 / #20170243350

Generating a suitable model for estimating patient radiation does from medical imaging scans

Techniques are disclosed for estimating patient radiation exposure during computerized tomography (ct) scans. More specifically, embodiments of the invention provide efficient approaches for generating a suitable patient model used to make such an estimate, to approaches for estimating patient dose by interpolating the results of multiple simulations, and to approaches for a service provider to host a dose estimation service made available to multiple ct scan providers.. ... Bayer Healthcare Llc

08/10/17 / #20170228860

Dose estimation service system configured to support multiple computerized medical imaging scan providers

Techniques are disclosed for estimating patient radiation exposure during computerized tomography (ct) scans. More specifically, embodiments of the invention provide efficient approaches for generating a suitable patient model used to make such an estimate, to approaches for estimating patient dose by interpolating the results of multiple simulations, and to approaches for a service provider to host a dose estimation service made available to multiple ct scan providers.. ... Bayer Healthcare Llc

08/10/17 / #20170224913

Front-loading medical injector adapted to releasably engage a syringe regardless of the orientation of the syringe with respect to the injector

A syringe for use with an injector includes a body having a rear end and a front end, a plunger movably disposed within the body, an attachment member associated with the body and adapted to releasably engage a syringe retaining mechanism of the injector regardless of the orientation of the syringe with respect to the injector, and an encoding device operable to provide syringe information to the injector.. . ... Bayer Healthcare Llc

08/03/17 / #20170218035

Compositions and methods for treatment with hemopexin

Compositions and methods are provided for therapeutic treatment using recombinant hemopexin molecules having sufficient sialyation and/or absence of neutral glycans to allow for sufficient circulation to remove free heme from a biological organism. In other embodiments, a recombinant hemopexin molecule is provided for therapeutic treatment having a percentage of neutral glycans to total glycans in a range of from about 2 to about 30 percent as measured by hplc after labelling with fluorescent probe 2-aminobenzoic acid. ... Bayer Healthcare Llc

07/13/17 / #20170197760

Fitment and container for powdered products, especially powdered products prone to clumping behavior

Fitment and container for powdered products, especially powdered products prone to clumping behavior, comprising a stopper that closes the passageway between the interior chamber and the mouth of the container, a pour spout in the stopper that permits the powdered product to flow through the passageway during a pouring operation, and one or more baffles connected to the stopper and extending into the interior chamber of the container, the baffles being configured to break apart clumps of the powdered product before the clumps can flow through the pour spout. The pour spout further includes a restriction element, associated with the pour spout, configured to break apart clumps that reach the pour spout without being broken apart by the baffles. ... Bayer Healthcare Llc

07/06/17 / #20170191025

Compounded media powder formulation and method of preparation of liquid medium for cell culture

The present invention provides a compounded cell culture medium powder formulation comprising: a basal medium powder and a cell culture media supplement, wherein the cell culture media supplement comprises and one or more salts; one or more growth factors; one or more inorganic ions; an amino acid supplement comprising one or more of asparagine, glutamine, histidine, and serine; one or more buffers; and one or more anti-foaming agents. The invention further provides methods of making a compounded cell culture medium powder formulation methods of making a cell culture medium for growing mammalian cells and methods of producing a protein of interest by culturing cells in the cell culture medium and isolating the protein of interest.. ... Bayer Healthcare Llc

06/29/17 / #20170182306

Magnetic medical connector and fluid transfer set including the magnetic medical connector

A connector for a fluid path set for delivery of a fluid to a patient during a procedure is described. The connector includes a magnetic check valve for limiting fluid flow to one direction through the fluid path. ... Bayer Healthcare Llc

06/22/17 / #20170172527

Combined radiopharmaceutical imaging system

. . An integrated radiopharmaceutical patient treatment system includes a portable radioisotope generation module configured to generate a gaseous radioisotope, a radiopharmaceutical processing module configured to dissolve the radioisotope in an injectable medical fluid, a fluid injection system in fluid communication with the radiopharmaceutical processing module and configured to inject a dose including the radioisotope and the injectable medical fluid into a patient, and at least two imaging devices configured to independently detect biological and physiological characteristics of the patient based on the dose. The radiopharmaceutical processing module may be in fluid communication with the radioisotope generation module.. ... Bayer Healthcare Llc

06/15/17 / #20170165427

Syringe and fluid injection system with an orientation independent identification code

A syringe is provided including an orientation independent indicia that can be used to validate and determine information about the syringe, injection parameters, and/or fluid contained therein. The syringe includes a syringe barrel and an indicia located on a portion of the syringe containing or associated with identifying information about the syringe, one or more injection parameters of a fluid injector, or a fluid filled in the syringe barrel. ... Bayer Healthcare Llc

06/15/17 / #20170165243

Pharmaceutical compositions for the treatment of hyper-proliferative disorders

This invention relates to novel pharmaceutical compositions comprising a solid dispersion of the compound of formula i below, to processes for preparing these novel pharmaceutical compositions and to their use for treating hyper-proliferative disorders, such as cancer, either as a sole agent or in combination with other therapies. Formula i is as follows:. ... Bayer Healthcare Llc

06/15/17 / #20170165242

Treatment of cancers with acquired resistance to kit inhibitors

The present invention provides compositions and methods for treating cancers which have acquired resistance to a kit inhibitor by administering effective amounts of dast.. . ... Bayer Healthcare Llc

06/15/17 / #20170165104

Occlusion implant

Contraceptive and/or sterilization methods and devices are disclosed which may improve the speed of tubal occlusion and mechanisms for anchoring for a contraceptive device. In accordance with some embodiments, improvements may be made to the delivery catheter to induce trauma and create faster tubal occlusion, improvements may be made to the occlusion device to prevent migration and induce trauma, and improvements may be made to the occlusion device to reduce the total volume of in-growth required compared to conventional expansive occlusion devices.. ... Bayer Healthcare Llc

06/01/17 / #20170154162

Systems and methods for managing adverse reactions in contrast media-based medical procedures

Described is a method of managing adverse reactions that may occur during a medical procedure that involves the administration of contrast media. The method includes acquiring, by a data acquisition unit, information about a patient and an upcoming medical procedure that involves the administration of contrast media, computing in advance of the medical procedure, by a risk assessment unit, a prediction of a risk that the patient will experience an adverse reaction to the contrast media based on the information about the patient and the upcoming medical procedure, and presenting to one or more medical personnel in advance of the medical procedure, by a risk alert unit, an indication of the risk in a visually perceptible form. ... Bayer Healthcare Llc

05/18/17 / #20170136424

Fluid path set with turbulent mixing chamber, back flow compensator

A fluid path set includes a first fluid line having a proximal end fluidly connectable to a source of a first fluid and a second fluid line having a proximal end fluidly connectable to a source of a second fluid. A flow mixing device is in fluid communication with distal ends of the first and second fluid lines. ... Bayer Healthcare Llc

05/11/17 / #20170128257

Hydration prevention coating

Occlusion devices and delivery systems are described in which a polymerizing oil is used to protect a hydrogel from premature swelling. In an embodiment, a delivery system includes an occlusion device releasably coupled within a catheter sheath. ... Bayer Healthcare Llc

05/04/17 / #20170123074

Generating an estimate of patient radiation dose from medical imaging scans

Techniques are disclosed for estimating patient radiation exposure during computerized tomography (ct) scans. More specifically, embodiments of the invention provide efficient approaches for generating a suitable patient model used to make such an estimate, to approaches for estimating patient dose by interpolating the results of multiple simulations, and to approaches for a service provider to host a dose estimation service made available to multiple ct scan providers.. ... Bayer Healthcare Llc

05/04/17 / #20170119963

System and method for syringe plunger engagement with an injector

A plunger for use with a syringe has a plunger body with a proximal end, a distal end, and a circumferential sidewall extending between the proximal end and the distal end along a plunger longitudinal axis. The plunger further has at least one resiliently deflectable retaining member having a first segment attached to the plunger body and a second segment protruding toward the distal end of the plunger body and deflectable relative to the first segment. ... Bayer Healthcare Llc

05/04/17 / #20170119962

Syringe identification using photochromic ink

A system for reading identifying information regarding a syringe assembly provided in a fluid injector is provided, the system including at least one syringe assembly having a syringe barrel with a distal end having a nozzle for expelling fluid therefrom and an open proximal end, the syringe barrel defining an interior volume, at least one indicator provided on at least a portion of an outer circumferential surface of the syringe barrel, the at least one indicator containing or associated with identifying information about the at least one syringe assembly, an injector having at least one syringe port configured to receive the at least one syringe assembly and to eject fluid therefrom, and a sensor module that activates the at least one indicator and receives information from the at least one indicator.. . ... Bayer Healthcare Llc

04/27/17 / #20170115156

Syringe with indicator float

A syringe assembly may include a syringe having a distal end, a proximal end, and a sidewall extending between the distal end and the proximal end and defining an interior volume; and an indicator float provided in the interior volume of the syringe. The indicator float may be buoyant such that the indicator float is movable between the distal end and the proximal end of the syringe based on a fluid fill level within the interior volume of the syringe.. ... Bayer Healthcare Llc

04/27/17 / #20170113004

Syringe drip guard

A syringe assembly may include a syringe having a distal end, a proximal end, and a sidewall extending between the distal end and the proximal end, and a syringe drip guard extending around at least a circumferential portion of the sidewall between the distal end and the proximal end of the syringe. The syringe drip guard may have an outer wall protruding radially outward relative to the sidewall. ... Bayer Healthcare Llc

04/27/17 / #20170112995

Tubing assembly

A tubing assembly for use with a fluid delivery system has a first fluid line having a distal end and a proximal end for connecting to a first fluid source, and a second fluid line having a distal end and a proximal end for connecting to a second fluid source. The tubing assembly further has a third fluid line having a distal end and a proximal end, and a connector assembly for connecting the distal end of the first fluid line and the distal end of the second fluid line to the proximal end of the third fluid line. ... Bayer Healthcare Llc

04/20/17 / #20170107298

Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)

Isolated monoclonal antibodies that bind to specific epitopes of human tissue factor pathway inhibitor (tfpi) and the isolated nucleic acid molecules encoding them are provided. Pharmaceutical compositions comprising the anti-tfpi monoclonal antibodies and methods of treating deficiencies or defects in coagulation by administration of the antibodies are also provided.. ... Bayer Healthcare Llc

04/13/17 / #20170100577

Flow based pressure isolation and fluid delivery system including flow based pressure isolation and flow initiating mechanism

The fluid delivery system includes a pressurizing device for delivering a pressurized injection fluid, a low pressure fluid delivery system, and a pressure isolation mechanism adapted for fluid communication with the pressurizing device and low pressure fluid delivery system. The pressure isolation mechanism includes a housing defining an inlet port, an isolation port, and an internal cavity. ... Bayer Healthcare Llc

03/30/17 / #20170087303

Medical fluid injector

Systems and methods for intelligently delivering fluid to a targeted tissue are described. The systems and methods may include directing a pump to distribute fluid to a targeted tissue and receiving one or more signals from an intracorporeal sensing system, where the one or more signals correspond to one or more sensed feedback parameters at the targeted tissue. ... Bayer Healthcare Llc

03/23/17 / #20170080148

System for syringe engagement to an injector

An injector system for injecting fluid includes a syringe and an injector. The syringe includes a body and a plunger movably disposed within the body. ... Bayer Healthcare Llc

03/16/17 / #20170072131

High pressure sensor for use with a fluid delivery system

A pressure sensor for use with a fluid delivery system having good sensitivity at low pressure, but also configured to remain in operating condition after being exposed to high pressures is disclosed herein. In one variation, the pressure sensor includes a fluid path set, a deformable element associated with the fluid path set and configured to deform in response to an external pressure, and a pressure transducer for monitoring deformation of the deformable element. ... Bayer Healthcare Llc

03/09/17 / #20170065770

Bladder syringe fluid delivery system

A bladder syringe for a fluid delivery system includes a cylindrical body, a cap-bladder assembly, a plunger element disposed in the cylindrical body, and a mounting assembly to secure the cap-bladder assembly to the cylindrical body. The cylindrical body has a distal end and a proximal end and defines a throughbore. ... Bayer Healthcare Llc

03/09/17 / #20170065763

Universal adapter for a medical injector and syringe identification system

A universal adapter for connecting a syringe to an injector is provided. The universal adapter for connecting a syringe to an injector includes: a body having a proximal end configured to connect to an injector; at least one radial support connected to the body and biased in an inward direction; and at least one axial support biased to position the syringe in an axial direction toward a distal end of the adapter. ... Bayer Healthcare Llc

03/02/17 / #20170056604

System and method for syringe fluid fill verification and image recognition of power injector system features

A fluid injection system and a fluid verification system for confirming that a syringe, containing a fluid for injection, is fully filled with fluid and neither has free space (i.e., air) near the distal end thereof when the syringe is provided in an upright position nor contains air bubbles. Imaging processing techniques and systems are also provided to determine various injection parameters and to verify the type and certain properties of fluid that is present within a syringe.. ... Bayer Healthcare Llc

03/02/17 / #20170056603

System and method for syringe fluid fill verification and image recognition of power injector system features

A fluid injection system and a fluid verification system for confirming that a syringe, containing a fluid for injection, is fully filled with fluid and neither has free space (i.e., air) near the distal end thereof when the syringe is provided in an upright position nor contains air bubbles. Imaging processing techniques and systems are also provided to determine various injection parameters and to verify the type and certain properties of fluid that is present within a syringe.. ... Bayer Healthcare Llc

02/23/17 / #20170051042

Targeted coagulation factors and method of using the same

Targeted coagulation factors comprising a coagulation factor linked with at least one domain that specifically binds to a membrane protein on a blood cell is provided. The disclosed targeted coagulation factors increase the efficiency of coagulation factors and prolong their duration of action and thus, are an improvement for the treatment of hematological diseases such as hemophilia a.. ... Bayer Healthcare Llc

02/23/17 / #20170049955

Multi-dose disposable system

A multi-dose disposable fluid delivery system includes at least one fluid container, a multi-use fluid path set, and a plurality of single-use fluid path sets. The at least one fluid container has a connection port configured for fluidly connecting with a first end of the multi-use fluid path set. ... Bayer Healthcare Llc

02/16/17 / #20170043083

Pumping devices, systems and methods for use with medical fluids including compensation for variations in pressure or flow rate

A system for delivery of a medical fluid to a patient includes a pump system including a pressurizing unit to pressurize the medical fluid and a drive system in operative connection with the pressurizing unit. The pump system exhibits variation in pressure during operation. ... Bayer Healthcare Llc

02/16/17 / #20170043082

Medical injector system

A syringe includes a body and a plunger movably disposed within the body. The syringe may be used with an injector including a drive member. ... Bayer Healthcare Llc

02/09/17 / #20170035959

Multi-fluid medical injector system and methods of operation

A multi-fluid injector system and methods of operation thereof are presented. One embodiment of such a fluid injector system includes an automatic refill procedure for a fluid injector system comprising a fluid injector and an operably engaged syringe. ... Bayer Healthcare Llc

02/02/17 / #20170027740

Contraceptive devices and methods

Contraceptive devices that provide substantially immediate and permanent sterilization are described herein. Systems and methods for transcervically delivering the contraceptive devices are also described herein. ... Bayer Healthcare Llc

02/02/17 / #20170027539

System and method to achieve rapid quantitative dynamic molecular imaging scans

Methods and systems for controlled administration of a tracer and quantification of uptake of the tracer by a target organ are described. The method includes administering a tracer to a patient and imaging at least two regions of the patient's body that cannot be imaged simultaneously. ... Bayer Healthcare Llc

02/02/17 / #20170027477

Method, apparatus, and computer-readable medium for generating a set of recommended orthotic products

In an embodiment, the present invention is an apparatus, comprising: a foot mat; a depth sensing camera; an elevated foot platform that reduces or prevents rotational movement of a foot; a processor in communication with the depth sensing camera, the processor further configured to calculate the circumference of a user's leg based on data from the depth sensing camera while the user has one foot on the foot mat and one foot on the elevated foot platform, the processor further configured to select a recommended product for the user's knee or ankle from among a set of pre-manufactured candidate products for knees or ankles based at least in part upon the leg circumference of the user; and an output device to display information received from the processor, the information identifying the recommended product to the user.. . ... Bayer Healthcare Llc

01/26/17 / #20170021193

System and method for planning and monitoring multi-dose radiopharmaceutical usage on radiopharmaceutical injectors

A method for planning and monitoring radiopharmaceutical usage during a plurality of radiopharmaceutical injection procedures includes: providing a schedule of the plurality of radiopharmaceutical injection procedures to produce a planned patient schedule; based on the planned patient schedule, calculating a multi-dose container configuration for use during the plurality of radiopharmaceutical injection procedures; transferring the planned patient schedule to a radiopharmaceutical fluid delivery system; loading the multi-dose patient configuration into the radiopharmaceutical fluid delivery system; and conducting the plurality of radiopharmaceutical injection procedures based on the planned patient schedule.. . ... Bayer Healthcare Llc

01/19/17 / #20170014568

Fluid delivery system and method of fluid delivery to a patient

A fluid delivery system includes a pressurizing mechanism. The pressurizing mechanism includes: a substantially cylindrical body having a movable member positioned therein that divides the body into a first chamber and a second chamber; a plunger rod connected to a first side of the movable member and extending through a substantially closed first end of the body; and an elongated member connected to a second side of the movable member and extending through a substantially closed second end of the body. ... Bayer Healthcare Llc

01/12/17 / #20170008965

Anti-prolactin receptor antibody formulations

Provided are a wide concentration range, especially high concentration, substantially salt-free anti-prolactin receptor antibody formulations that are substantially isosmotic and of low viscosity.. . ... Bayer Healthcare Llc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Bayer Healthcare Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Bayer Healthcare Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###